razoxane has been researched along with Stomach Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashford, RF; Bakowski, M; Evans, M; Hellman, K; Jones, R; Lambert, J; Newton, K; Peters, N; Phillips, R; Smith, BJ | 1 |
| Bunn, PA; Cohen, MH; Eddy, J; Ihde, DC; Krasnow, S; Matthews, MJ; Minna, JD | 1 |
| Cassell, P; Ellis, H; Gilbert, JM; Hellman, K; Hermon-Taylor, J; Wastell, C | 1 |
| Goold, M; Hellmann, K; Higgins, N; Phillips, RH | 1 |
| He, SQ; Li, CF; Liu, TF; Zhen, XY; Zhou, J | 1 |
1 trial(s) available for razoxane and Stomach Neoplasms
| Article | Year |
|---|---|
A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
Topics: Adenocarcinoma; Clinical Trials as Topic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Piperazines; Prognosis; Razoxane; Rectal Neoplasms; Stomach Neoplasms | 1983 |
4 other study(ies) available for razoxane and Stomach Neoplasms
| Article | Year |
|---|---|
ICRF-159 in advanced gastric cancer. Absence of activity.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Stomach Neoplasms | 1982 |
Adjuvant treatment with razoxane (ICRF 159) following resection of cancer of the stomach.
Topics: Drug Administration Schedule; Humans; Piperazines; Razoxane; Stomach Neoplasms | 1978 |
Responses of liver metastases to radiotherapy and razoxane.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Razoxane; Stomach Neoplasms; Tomography, X-Ray Computed | 1992 |
Radiation survival properties of cultured human gastric adenocarcinoma cells and the effect of AT-1727.
Topics: Adenocarcinoma; Cell Survival; DNA Repair; Humans; In Vitro Techniques; Piperazines; Radiation-Sensitizing Agents; Razoxane; Stomach Neoplasms; Tumor Cells, Cultured | 1989 |